Lord, Abbett & Co
ARRY

Lord, Abbett & Co’s Array Biopharma Inc ARRY Stock Holding History

Lord, Abbett & Co’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-901,813
Closed -$22M – 848
2019
Q1 		$22M Buy
+901,813
New +$18.8M 0.07% 392
2015
Q3 		– Sell
-14,300
Closed -$103K – 992
2015
Q2 		$103K Buy
+14,300
New +$106K ﹤0.01% 916
2013
Q4 		– Sell
-1,349,084
Closed -$8.39M – 1119
2013
Q3 		$8.39M Buy
1,349,084
+880,285
+188% +$5.23M 0.02% 679
2013
Q2 		$2.13M Buy
+468,799
New +$2.52M ﹤0.01% 944

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return